Product
PPI-1011
1 clinical trial
1 indication
Indication
Rhizomelic Chondrodysplasia PunctataClinical trial
A Phase 1, Randomized, Double-blind, Placebo-controlled, Combined Single and Multiple Ascending Dose Study of PPI-1011 in Subjects to Assess Safety, Tolerability, and PharmacokineticsStatus: Recruiting, Estimated PCD: 2023-11-30